Bosutinib

Common brands: Bosulif, Sprycel, Tasigna, Imatinib Mesylate, Dasatinib

Top reporter: Pfizer Laboratories Div Pfizer Inc

Kinase Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Loop Diuretic [EPC]Platelet Aggregation Inhibitor [EPC]Xanthine Oxidase Inhibitor [EPC]
8,855
Total Reports
4,196
Serious Reports
764
Death Reports
30
Reported Reactions
Death Report Ratio: High (8.63%)

Patient Demographics

Male
3,954
Female
4,092

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Bosutinib.

# Reaction Reports % of Total
1 DIARRHOEA 2,060
18.1%
2 NAUSEA 1,012
8.9%
3 FATIGUE 722
6.4%
4 VOMITING 536
4.7%
5 DEATH 514
4.5%
6 RASH 490
4.3%
7 PLEURAL EFFUSION 448
3.9%
8 NEOPLASM PROGRESSION 373
3.3%
9 DYSPNOEA 361
3.2%
10 HEADACHE 335
2.9%
11 OFF LABEL USE 322
2.8%
12 DRUG INTOLERANCE 313
2.8%
13 MALAISE 298
2.6%
14 DRUG INEFFECTIVE 274
2.4%
15 ABDOMINAL PAIN 263
2.3%
16 ARTHRALGIA 252
2.2%
17 ABDOMINAL PAIN UPPER 246
2.2%
18 ASTHENIA 246
2.2%
19 PAIN 220
1.9%
20 WEIGHT DECREASED 218
1.9%
21 ABDOMINAL DISCOMFORT 212
1.9%
22 CONSTIPATION 207
1.8%
23 PNEUMONIA 206
1.8%
24 PYREXIA 196
1.7%
25 DECREASED APPETITE 194
1.7%
26 ILLNESS 190
1.7%
27 DIZZINESS 183
1.6%
28 PRURITUS 175
1.5%
29 BACK PAIN 152
1.3%
30 ANAEMIA 151
1.3%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.